Klimczak Named NIH Associate Director for Legislative Policy, Analysis
Katherine “Kate” Klimczak has been named NIH associate director for legislative policy and analysis and director of the NIH Office of Legislative Policy and Analysis (OLPA). She returned to NIH from the U.S. Food and Drug Administration, which she joined in 2019 to serve as deputy director of its congressional appropriations office.
While with FDA, Klimczak oversaw the formulation and execution of FDA’s annual appropriations strategy; advised senior FDA leadership on actions, policies and issues concerning appropriations, legislation and oversight activities; and managed the implementation of legislative action plans to ensure that the FDA complied with legislative requirements.
Previously at NIH, Klimczak served as an OLPA senior legislative analyst. She managed NIH’s interactions and relationships with congressional appropriation committees. She also led negotiations with Congress for NIH’s budget and legislative needs. At the Department of Health and Human Services (HHS), she served as a congressional liaison specialist, formulating HHS legislative appropriations strategies.
Klimczak has a bachelor’s degree in government from Georgetown University and a master of public policy degree from Duke University.